Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit

Anticancer Research

Volumn 22, Issue 6 A, 2002, Pages 3281-3284

  Mandic, R ^a   Dunne A A ^a   Eikelkamp, N ^a   Ramaswamy, A ^a   Schulz, S ^a   Teymoortash, A ^a   Sesterhenn, A ^a   Moll, R ^a   Werner, J A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Head and neck; Metastasis; MMP; New Zealand white rabbit; Squamous cell carcinoma; TIMP; VX2 carcinoma

Indexed keywords

ANTIBODY; COLLAGENASE 3; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CANCER MODEL; CANCER TRANSPLANTATION; EVALUATION; HEAD AND NECK CARCINOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RISK FACTOR; SIGNAL DETECTION; SQUAMOUS CELL CARCINOMA; STANDARD; WESTERN BLOTTING;

ANIMALS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; COLLAGENASES; DISEASE MODELS, ANIMAL; EAR NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; RABBITS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 0036870209     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Werner JA: Aktueller stand der versorgung des lymphabflusses maligner kopf-hals-tumoren. Eur Arch Otorhinolaryngol Suppl I: 47-85, 1997.
2. Gersh I and Catchpole HR: The organization of ground substance and basement membrane and its significance in tissue injury, disease ad growth. Am J Anat 85: 457-507, 1949.
3. Riley WBJ and Peacock EEJ: Identification, distribution, and significance of a collagenolytic enzyme in human tissues. Proc Soc Exp Biol Med 124: 207-210, 1967.
4. Taylor AC, Levy BM and Simpson JW: Collagenolytic activity of sarcoma tissues in culture. Nature 228: 366-367, 1970.
5. Cazorla M, Hernandez L and Nadal A: Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 186: 144-150, 1998.
6. Liotta LA, Rao CN and Wewer UM: Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 55: 1037-1057, 1986.
7. Kurahara S, Shinohara M and Ikebe T: Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21: 627-638, 1999.
8. Polette M, Clavel C, Birembaut P and De Clerck YA: Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol Res Pract 189: 1052-1057, 1993.
9. Magary SP, Ryan MW, Tarnuzzer RW and Kornberg L: Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in laryngeal and pharyngeal squamous cell carcinoma: A quantitative analysis. Otolaryngol Head Neck Surg 122: 712-716, 2000.
10. Kawamata H, Uchida D and Hamano H: Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol 13: 699-704, 1998.
11. Miyajima Y, Nakano R and Morimatsu M: Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization. Ann Otol Rhinol Laryngol 104: 678-684, 1995.
12. Tokumaru Y, Fujii M, Otani Y, Kameyama K, Imanishi Y, Igarashi N and Kanzaki J: Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in vitro cell lines co-cultured with fibroblasts. Cancer Lett 150: 15-21, 2000.
13. Kusukawa J, Sasaguri Y, Morimatsu M and Kameyama T: Expression of matrix metalloproteinase-3 in stage I and II squamous cell carcinoma of the oral cavity. J Oral Maxillofac Surg 53: 530-534, 1995.
14. Sato H, Takino T and Okada Y: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994.
15. Falkenberg S, Rathcke IO, Lippert BM, Folz BJ and Werner JA: Expression of MMP-2, -7, -9, and -13 as well as TIMP-1, -2, and -3 in squamous cell carcinomas of the head and neck. J Cancer Res Clin Oncol 125: 122-122, 1999.
16. Heissenberg MC, Gorogh T, Lippert BM and Werner JA: Metalloproteinases and their inhibitors in squamous cell carcinoma of the hypopharynx: indicators of individual tumor aggressiveness. Otolaryngol Pol 52: 521-526, 1998.
17. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U and Kahari VM: Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151: 499-508, 1997.
18. Sato H: Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Hum Pathol 31: 895-904, 2000.
19. Yamamoto H, Adachi Y and Itoh F: Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 59: 3313-3316, 1999.
20. Shinohara M, Nakamura S, Harada T, Shimada M and Oka M: Mode of tumor invasion in oral squamous cell carcinoma: improved grading based on immunohistochemical examination of extracellular matrices. Head Neck 18: 153-159, 1996.
21. Riedel F, Gotte K, Schwalb J and Hormann K: Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma. Anticancer Res 20: 3045-3049, 2000.
22. O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM and Eccles SA: Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res 60:1121-1128, 2000.
23. O-charoenrat P, Rhys-Evans P, Court WJ, Box GM and Eccles SA: Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands. Clin Exp Metastasis 17: 631-639, 1999.
24. Dünne AA, Kulkens C, Ramaswamy A, Folz BJ, Brandt D, Lippert BM, Th Behr, Moll R and Werner JA: Value of sentinel lymphonodectomy in patients with squamous cell carcinoma of the head and neck. Auris Nasus Larynx 28: 339-344, 2001.
25. Werner JA, Dunne AA, Ramaswamy A, Folz BJ, Kulkens Ch, Moll R, Behr T and Lippert BM: Number and location of radiolabeled, intraoperatively identified sentinel nodes in 48 head and neck cancer patients with clinically staged N0 and N1 neck. Eur Arch Otorhinolaryngol 259: 91-94, 2002.
26. Dünne AA, Plehn S, Schulz S, Mandic R, Levermann A, Ramaswamy A, Lippert BM and Werner JA: Lymph node topography of the head and neck in New Zealand white rabbits. Laboratory Animals (in press).
27. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2000.
28. Dünne AA, Mandic R, Ramaswamy A, Plehn S, Schulz S, Lippert BM, Moll R and Werner JA: Lymphogenic metastatic spread of auricular VX2 carcinoma in New Zealand white rabbits. Anticancer Res 22: 3273-3280, 2002.
29. Goldberg GL, Strongin A, Collier IE, Genrich LT and Marmer BL: Interaction of 92 kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267: 4583-4591, 1992.
30. Olson MW et al: Characterization of the monomeric and dimeric forms of latent and active metalloproteinase-9. Differential rates for activation by stromelysin1. J Biol Chem 28: 275(4): 2661-8, 2000.